SANT Santeon Group Inc (PK)

Santeon Group, Inc. (OTCQB: SANT) today announced it has released the Team, Professional and Enterprise versions of Dr.Agile, a cloud-based Agile Practice Self-Assessment tool.

With the rapid adoption of Agile as a transformational path to managing value-based software projects, increasing demand has given rise to a new breed of software products that enable organizations to manage the Agile software development lifecycle. At the forefront of these tools is the need for groups at the team, department, division and enterprise levels to measure their readiness of adopting an Agile-based approach.

Santeon's Dr.Agile cloud-based self-assessment software uses a comprehensive and sophisticated proprietary algorithm calculation derived from extensive research, tested in large enterprises comprising thousands of users and based on over 65,000 data points. Our self-assessment approach considers existing or planned agile practices an organization is using and, based on survey results from various members in the organization, assigns weighted values to organizational characteristics that enable the successful adoption of agile practices. Dr.Agile is unique in the industry with sophisticated logarithmic levels of analysis and in-depth reporting. Dr.Agile releases a different survey for each role in the organization and it assesses not just whether a team is employing an agile practice or not, but also testing for the existence of the underlying enablers and value realized from proper agile implementation.

Santeon is proud once again to lead the market with revolutionary and comprehensive products that set organizations on a successful and measureable path to an Agile mindset. To learn more about Dr.Agile, please visit www.dragile.com.

"We are very proud of the depth and sophistication of Dr.Agile as a state-of-the-art self-assessment tool. Dr.Agile is an essential self-assessment tool for every team and organization doing agile or aspiring to do Agile because it highlights the risks that may hinder the real adoption of Agile practices and will inform an organization of what needs to be improved to take your "agility" to the next level," commented Dr. Ahmed Sidky, Executive Vice President and Agile Practice Leader, on the launch of Dr.Agile. Dr. Sidky continued, "As teams start their journey toward becoming Agile, it is common to see them doing the practices without realizing real change in behavior and mindset. Dr.Agile was designed to help with precisely that: measuring the potential of becoming truly Agile."

"This is the first of a group of products we plan on releasing to address growing customer demand, specifically in the Agile arena. We have taken our years of experience working with small teams and large enterprises developing transformational roadmaps and successfully packaged those learned lessons into a comprehensive and sophisticated product. This is certainly a game-changing product and one more example of Santeon's thought-leadership position in Agile transformation," commented Dr. Ashraf Rofail, Chairman and CEO of Santeon.

Santeon's release of "Dr.Agile" coincides with the Annual AgileDC conference in Washington, DC. Santeon has three Agile team members presenting at the AgileDC conference, including Dr. Ahmed Sidky -- a first for Santeon.

About Santeon Group, Inc. Santeon Group, Inc. is a technology company headquartered in Northern Virginia with offices in Reston, VA, Tampa, FL, Cairo, Egypt and Pune, India. Santeon offers products and services in Agile training and transformation, healthcare and media. Santeon's goal is to serve emerging markets by providing technically superior products and solutions while reducing the cost of ownership and deployment of these solutions through a strong channel partner and distribution model. For more information please visit our web site at http://www.santeon.com.

Safe Harbor Statement: The preceding press release may include, among others, forward-looking statements regarding our beliefs, plans, objectives, goals, expectations, estimates and intentions that are subject to significant risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. The words "may," "could," "should," "would," "believe," "anticipate," "estimate," "expect," "intend," "plan," "target," "goal" and similar expressions are intended to identify forward-looking statements. All forward-looking statements, by their nature, are subject to risks and uncertainties. Our actual future results may differ materially from those set forth in the forward-looking statements. Our ability to achieve our financial objectives could be adversely affected by many factors, including, without limitation, the following factors: the strength of the United States economy, changes in securities markets legislative or regulatory changes, the loss of key personnel, the loss of key vendors, technological changes, changes in customer habits, changes in vendor habits, services or policies, our ability to manage these and other risks, and our ability to deliver products and services on time. However, other factors besides those listed above could adversely affect our results, and you should not consider any such list of factors to be a complete set of all potential risks or uncertainties. These forward-looking statements are not guarantees of future performance, but reflect the present expectations of future events by our management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Any forward-looking statements made by us speak only as of the date they are made. We do not undertake to update any forward-looking statement, except as required by applicable law. For additional information about Santeon's future business and financial results, refer to Santeon's Annual Report on Form 10-K that may be found at sec.gov or on http://santeon.com/Sec_Filings.html. Santeon undertakes no obligation to update any forward-looking statements that may be made from time to time by the company, whether as a result of new information, future events or otherwise.

Investor Relations Contacts: Mark Guirgis Santeon Group, Inc. 703-970-9200, ext. 112 markguirgis@santeon.com